Alta Advisers LTD Bristol Myers Squibb CO Transaction History
Alta Advisers LTD
- $230 Million
- Q1 2025
A detailed history of Alta Advisers LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alta Advisers LTD holds 10,150 shares of BMY stock, worth $509,530. This represents 0.27% of its overall portfolio holdings.
Number of Shares
10,150
Previous 6,750
50.37%
Holding current value
$509,530
Previous $381,000
62.47%
% of portfolio
0.27%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,784Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.54 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.96 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.82 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.78 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.03 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...